BRCA1 and hereditary cancer: Because of the potential to miss such mutations, re-testing of individuals who previously had limited BRCA1 and BRCA2 testing should be considered, particularly in ethnicities with elevated risk or if a strong suspicion for hereditary cancer otherwise remains.